Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

Study highlights major impact of RSV on older adults​
Studies look at RSV uptake among veterans, ICU risk factors for older patients​
Quick takes: EMA lifts chikungunya vaccine restriction, another Nipah case from India, expanded indication review for Arexvy​
New data reveal impact of RSV on kids with chronic conditions, plus high adult exposure​
Shingles, RSV vaccines may protect older adults from dementia​
RSV hospitalization in adults tied to risk of death and kidney, heart problems​
ACIP draft agenda revives anti-vaccine boilerplate topics​
Moderna receives expanded approval for RSV vaccine​
FDA approves Merck RSV monoclonal antibody shot for infants​
Flu, RSV linked to higher odds of secondary bacterial infection​
Medical societies recommend RSV vaccines for older or immune-compromised adults​
Up to 56,000 people died from COVID-19 or RSV last year​
Rapid RSV tests linked to less antibiotic prescribing in kids​
Up to 56,000 people died from COVID-19 or RSV last year​
US flu activity still high, with 8 more pediatric deaths​
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates​
CDC reports 6 more child deaths from flu, as virus levels stay moderate to high​
Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months​
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%​
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women​